More MS news articles for May 2004

Low Dose Rebif Not Effective in SPMS

http://www.bostoncure.org:8080/article.pl?sid=04/05/05/117221&mode=nested

May 1, 2004
Art Mellor
Boston Cure Project

Here's a quick negative study that found that Interferon beta-1a (Rebif(R)), 22 micro g subcutaneously once weekly, in patients with secondary progressive MS did not delay progression of disease. My guess is they'll try higher doses next.